Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Amgen Inc. Stock Price (Quote) NASDAQ:AMGN
$207.84 ( 0.51% ) Friday, 15th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $200.47 | $219.92 | Friday, 15th Oct 2021 AMGN stock ended at $207.84. This is 0.51% more than the trading day before Thursday, 14th Oct 2021. During the day the stock fluctuated 1.35% from a day low at $206.23 to a day high of $209.02. |
| 90 days | $200.47 | $250.39 | |
| 52 weeks | $200.47 | $276.69 |
Historical Amgen Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-15 | $208.49 | $209.02 | $206.23 | $207.84 | 3 674 937 |
| 2021-10-14 | $204.49 | $207.50 | $204.49 | $206.78 | 3 014 977 |
| 2021-10-13 | $202.82 | $204.89 | $202.10 | $203.61 | 3 247 195 |
| 2021-10-12 | $207.43 | $207.56 | $200.47 | $201.89 | 3 522 681 |
| 2021-10-11 | $209.06 | $209.89 | $206.59 | $206.70 | 1 974 930 |
| 2021-10-08 | $210.13 | $210.18 | $207.65 | $208.95 | 2 348 462 |
| 2021-10-07 | $208.53 | $212.45 | $208.53 | $209.12 | 3 320 080 |
| 2021-10-06 | $211.32 | $212.08 | $208.97 | $209.98 | 2 864 836 |
| 2021-10-05 | $211.21 | $213.99 | $211.08 | $211.86 | 2 462 355 |
| 2021-10-04 | $214.10 | $215.64 | $210.77 | $211.44 | 2 855 024 |
| 2021-10-01 | $213.59 | $214.61 | $210.80 | $213.92 | 2 629 135 |
| 2021-09-30 | $215.79 | $216.67 | $212.52 | $212.65 | 2 463 329 |
| 2021-09-29 | $212.50 | $216.80 | $211.85 | $214.90 | 1 895 925 |
| 2021-09-28 | $212.30 | $214.76 | $211.65 | $212.27 | 2 853 002 |
| 2021-09-27 | $213.25 | $214.95 | $212.70 | $213.11 | 1 941 373 |
| 2021-09-24 | $214.75 | $215.53 | $213.20 | $213.61 | 1 907 322 |
| 2021-09-23 | $212.51 | $215.56 | $212.30 | $215.05 | 2 181 307 |
| 2021-09-22 | $216.56 | $216.56 | $213.46 | $213.64 | 2 477 141 |
| 2021-09-21 | $215.71 | $218.10 | $214.36 | $215.36 | 2 111 544 |
| 2021-09-20 | $218.38 | $219.85 | $214.28 | $215.11 | 3 079 462 |
| 2021-09-17 | $217.23 | $219.88 | $215.87 | $219.38 | 5 478 110 |
| 2021-09-16 | $218.02 | $218.65 | $214.00 | $217.36 | 2 580 248 |
| 2021-09-15 | $216.77 | $219.92 | $215.86 | $218.13 | 2 522 574 |
| 2021-09-14 | $217.60 | $217.92 | $215.12 | $216.04 | 1 947 978 |
| 2021-09-13 | $217.06 | $219.05 | $215.07 | $216.72 | 2 537 403 |
| 2021-09-10 | $216.50 | $216.99 | $213.55 | $213.75 | 2 201 281 |
| 2021-09-09 | $220.50 | $220.65 | $215.41 | $215.58 | 3 272 335 |
| 2021-09-08 | $221.33 | $222.29 | $220.10 | $220.87 | 2 135 240 |
| 2021-09-07 | $223.00 | $224.94 | $219.52 | $221.34 | 3 281 238 |
| 2021-09-03 | $225.76 | $227.19 | $224.20 | $226.37 | 1 654 620 |
| 2021-09-02 | $223.64 | $226.03 | $223.43 | $225.96 | 1 817 701 |
| 2021-09-01 | $225.55 | $226.12 | $221.88 | $223.35 | 2 693 936 |
| 2021-08-31 | $224.94 | $225.65 | $223.34 | $225.53 | 2 881 151 |
| 2021-08-30 | $222.28 | $225.31 | $222.10 | $224.13 | 1 862 727 |
| 2021-08-27 | $222.22 | $225.36 | $220.22 | $222.78 | 2 655 793 |
| 2021-08-26 | $222.06 | $222.06 | $220.16 | $221.47 | 2 841 737 |
| 2021-08-25 | $224.31 | $224.83 | $221.18 | $221.59 | 2 118 633 |
| 2021-08-24 | $225.52 | $225.68 | $223.56 | $224.38 | 1 788 304 |
| 2021-08-23 | $224.18 | $227.44 | $223.77 | $225.64 | 1 881 614 |
| 2021-08-20 | $224.39 | $226.24 | $222.01 | $223.53 | 2 705 838 |
| 2021-08-19 | $225.69 | $227.70 | $223.30 | $224.39 | 2 645 171 |
| 2021-08-18 | $230.52 | $231.33 | $226.60 | $226.84 | 2 976 798 |
| 2021-08-17 | $229.66 | $231.28 | $229.52 | $231.20 | 2 664 953 |
| 2021-08-16 | $228.26 | $231.29 | $227.92 | $231.07 | 2 407 040 |
| 2021-08-13 | $229.11 | $231.89 | $228.76 | $229.68 | 1 796 687 |
| 2021-08-12 | $228.20 | $229.48 | $225.81 | $228.15 | 1 797 694 |
| 2021-08-11 | $229.14 | $230.00 | $227.49 | $228.13 | 2 095 841 |
| 2021-08-10 | $228.20 | $228.20 | $223.94 | $227.96 | 2 860 008 |
| 2021-08-09 | $230.52 | $231.40 | $227.22 | $227.89 | 2 249 315 |
| 2021-08-06 | $231.85 | $233.25 | $228.77 | $230.15 | 2 294 803 |
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The companys principal products include Neulasta, a pegylated protein to decrease the incidence of infection associated with chemotherapy-induced febrile neutropenia in cancer patients; NEUPOGEN, a rec... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
